Aly-Khan Lalani, MD of Dana-Farber Cancer Institute gives an overview of practice-changing data coming out of ASCO on metastatic hormone-sensitive…
Browsing: Acute Lymphoblastic Leukemia
Mark M. Awad, MD, PhD of Dana-Farber Cancer Institute gives an overview of his abstract, Impact of MET inhibitors on…
Mark M. Awad, MD, PhD of Dana-Farber Cancer Institute discusses common questions colleagues ask him regarding his abstract at the…
Mark M. Awad, MD, PhD of Dana-Farber Cancer Institute discusses the impact of his study on clinical practice and future…
Mark M. Awad, MD, PhD of Dana-Farber Cancer Institute summarizes the next steps for METdel14 mutations and MET inhibitors for…
J. Thaddeus Beck, MD, FACP of Highlands Oncology Group gives an overview of his presentation, which focused on the use…
J. Thaddeus Beck, MD, FACP of Highlands Oncology Group discusses common questions colleagues ask him regarding the IBM Watson platform…
J. Thaddeus Beck, MD, FACP of Highlands Oncology Group discusses the impact of IBM Watson on clinical practice and future…
Shailender Bhatia, MD of Seattle Cancer Care Alliance discusses his first presentation, which focused on the results of the KEYNOTE-029…
Shailender Bhatia, MD of Seattle Cancer Care Alliance discusses his second presentation, which focused on the use of nivolumab plus…
Shailender Bhatia, MD of Seattle Cancer Care Alliance discusses what the next steps are for these two clinical trials and…
Brian Rini, MD of Cleveland Clinic gives an overview of the poster presentations on kidney cancer at the 2017 ASCO…
Brian Rini, MD of Cleveland Clinic gives an overview of his poster presentation which focuses on the use of sunitinib…
Brian Rini, MD of Cleveland Clinic discusses the treatment trends for kidney cancer in the next couple of years which…
Sharad A. Ghamande, MD of Medical College of Georgia discusses the take-home message of the AIM2CERV trial at the 2017…
Sharad A. Ghamande, MD of Medical College of Georgia discusses how he communicates and encourages his patients to participate in…
Sharad A. Ghamande, MD of Medical College of Georgia gives an overview of poster presentations he found the most interesting…
Sharad A. Ghamande, MD of Medical College of Georgia discusses the unmet need for cervical cancer and the promising data…
Aditya Bardia, MD, MPH of Harvard Medical School and Massachusetts General Hospital Cancer Center gives an overview of the treatment…
Aditya Bardia, MD, MPH of Harvard Medical School and Massachusetts General Hospital Cancer Center discusses the next step for RAD1901…
Aditya Bardia, MD, MPH of Harvard Medical School and Massachusetts General Hospital Cancer Center gives an overview of his presentation,…
Aditya Bardia, MD, MPH of Harvard Medical School and Massachusetts General Hospital Cancer Center discusses common questions he’s asked regarding…
Adi Diab, MD of MD Anderson Cancer Center discusses the treatment trends for 2017 in oncology, which include combining immunotherapies…
Adi Diab, MD of MD Anderson Cancer Center gives an overview of the promising data on intratumoral therapy that was…
Adi Diab, MD of MD Anderson Cancer Center discusses the impact of cytokine therapy and NKTR-214 on clinical practice and…
Adi Diab, MD of MD Anderson Cancer Center discusses a common question he’s asked, regarding the use of NKTR-214 for…
Adi Diab, MD of MD Anderson Cancer Center gives an overview of his abstracts, which focus on the use of…
Steven E. Benner, MD, Senior Vice President and Global Therapeutic Head for Oncology at Astellas Oncology discusses whether or not…
Steven E. Benner, MD, Senior Vice President and Global Therapeutic Head for Oncology at Astellas Oncology the future of treatment…
Steven E. Benner, MD, Senior Vice President and Global Therapeutic Head for Oncology at Astellas Oncology discusses a phase 1…
Steven E. Benner, MD, Senior Vice President and Global Therapeutic Head for Oncology at Astellas Oncology gives an overview of…
Steven E. Benner, MD, Senior Vice President and Global Therapeutic Head for Oncology at Astellas Oncology discusses the use of…
Steven E. Benner, MD, Senior Vice President and Global Therapeutic Head for Oncology at Astellas Oncology gives an overview of…
Kelly Garneski Paulson, MD of Seattle Cancer Care Alliance gives an overview and background context on her abstract which focuses…
Kelly Garneski Paulson, MD of Seattle Cancer Care Alliance discusses what’s next in the future for her clinical trial on…
Kelly Garneski Paulson, MD of Seattle Cancer Care Alliance explains what epitopes are in merkel cell carcinoma. This was recorded…
Kelly Garneski Paulson, MD of Seattle Cancer Care Alliance gives an overview of her poster presentation which focuses on two…
Nancy E. Davidson, MD of Seattle Cancer Care Alliance discusses the promising data coming out of SCCA for acute lymphoblastic…
Nancy E. Davidson, MD of Seattle Cancer Care Alliance stresses the importance of patient advocacy, quality of life, and cancer…
Nancy E. Davidson, MD of Seattle Cancer Care Alliance gives an overview of a joint session between American Association of…
Nancy E. Davidson, MD of Seattle Cancer Care Alliance discusses plans the center has on the future of cost and…
Shinji Atagi, MD of National Hospital Organization Kinki-Chuo Chest Medical Center gives an overview of a randomized trial done by…
Jonathan Lim, MD, Chairman and CEO of Ignyta, Inc. discusses what’s next for entrectinib and his hopes to launch the…
Jonathan Lim, MD, Chairman and CEO of Ignyta, Inc. gives an overview of his clinical trial, STARTRK-2 and the use…
Jonathan Lim, MD, Chairman and CEO of Ignyta, Inc. explains the impact of Entrectinib and the STARTRK-2 trial on clinical…
Jonathan Lim, MD, Chairman and CEO of Ignyta, Inc. explains genomic testing in finding patients for the clinical trial, STARTRK-2.…
David Michael Hyman, MD of Memorial Sloan-Kettering talks of his hopes for LOXO-101 in future clinical practice and clinical trials…
David Michael Hyman, MD of Memorial Sloan-Kettering gives an overview his presentation, which focuses on the efficacy of larotrectinib (LOXO-101)…
David Michael Hyman, MD of Memorial Sloan-Kettering explains common questions physicians ask him concerning his study on the efficacy of…
William P. Harris, MD of Seattle Cancer Care Alliance gives an overview of some of the promising data coming out…